{"id":"W4224290890","doi":"10.1056/nejmoa2117344","title":"Ivosidenib and Azacitidine in <i>IDH1</i> -Mutated Acute Myeloid Leukemia","year":2022,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":483,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Servier; Agios Pharmaceuticals","keywords":"Azacitidine; Medicine; Placebo; Myeloid leukemia; Internal medicine; Hazard ratio; Clinical endpoint; Population; Oncology; Randomized controlled trial; Surgery; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002273686,0.0002324577,0.0008699419,0.0008175488,0.0001170002,0.00001225506,0.0002507197,0.00007291503,0.0009704539],"category_scores_gemma":[0.0005327254,0.0001690482,0.00007808851,0.0007837273,0.0001956784,0.0001436359,0.0001701169,0.001811043,0.000004862701],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009243836,"about_ca_system_score_gemma":0.001285466,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004398336,"about_ca_topic_score_gemma":0.00004267491,"domain_scores_codex":[0.9970067,0.0002591292,0.0008766862,0.0002491019,0.001166683,0.0004417688],"domain_scores_gemma":[0.9982356,0.0003811769,0.0003179301,0.0002422335,0.0001981022,0.0006249615],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.02093328,0.0002940858,0.05172461,0.0002428592,0.001089821,0.04258906,0.008974263,0.0004755799,0.3556592,0.0004294961,0.2180544,0.2995334],"study_design_scores_gemma":[0.4215765,0.01686169,0.04073457,0.001085626,0.001149466,0.1242035,0.003753153,0.001774708,0.007994995,0.002610224,0.3776016,0.0006539106],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9624831,0.003590802,0.0001233911,0.03107581,0.0004071503,0.0002994876,0.000008324728,0.00002149113,0.001990461],"genre_scores_gemma":[0.9901996,0.002223413,0.0006553273,0.002601883,0.002215243,0.000007025968,0.00002511617,0.00004396272,0.002028474],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4006432,"threshold_uncertainty_score":0.9999428,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01712971759250661,"score_gpt":0.2887805397604379,"score_spread":0.2716508221679313,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}